Medical/Pharmaceuticals
First Patient Enrolled in the US Phase 2 Combination Therapy of Akeso's Ligufalimab with Azacitidine for Myelodysplastic Syndrome
HONG KONG, Aug. 6, 2024 /PRNewswire/ -- Akeso has announced the completion of the first patient enrollment in the US for the phase II clinical trial of its innovative CD47 monoclonal antibody, ligufalimab (AK117), in combination with azacitidine for patients with newly diagnosed higher-risk myelo...
2024-08-06 12:44
2404
OBiO Technology Congratulates on The First Clinical Gene Editing Therapy to Treat An Overseas Patient in China by CorrectSequence Therapeutics
SHANGHAI, Aug. 5, 2024 /PRNewswire/ -- Recently, CorrectSequence Therapeutics Co., Ltd. (Correctseq) announced a significant milestone in their base editing therapy CS-101 for transfusion-dependent β-thalassemia. Utilizing their pioneering transformer Base Editor (tBE), Correctseq has successfull...
2024-08-06 11:01
2619
Terumo Establishes Corporate Venture Capital "Terumo Ventures"
TOKYO, Aug. 6, 2024 /PRNewswire/ -- Terumo Corporation (TSE: 4543) today announced that it has established "Terumo Ventures," a Corporate Venture Capital (CVC) organization responsible for leading the Group's venture investments, as a department within Terumo Americas Holding, Inc. Terumo Vent...
2024-08-06 09:00
3405
VISTA Eye Specialist Launches Corporate Program to Combat Rising Workplace Eye Issues
PETALING JAYA, Malaysia, Aug. 6, 2024 /PRNewswire/ -- VISTA Eye Specialist ("VISTA"), a leading provider of eye care services, today announced the launch of its Premier Corporate Partner Program. This initiative aims to combat the rising incidence of eye diseases, including dry eye caused by prol...
2024-08-06 08:00
2341
Antengene Announces XPOVIO® (selinexor) Approved for Commercialization in Malaysia
* XPOVIO® is the first and only approved XPO1 inhibitor in Malaysia. * XPOVIO® has been approved for multiple indications in eight markets across the APAC region. Antengene has submitted new drug applications (NDAs) for XPOVIO ® in other ASEAN markets including Thailand and Indonesia with app...
2024-08-06 08:00
2841
Everest Medicines to Announce 2024 Interim Results on August 28, 2024
SHANGHAI, Aug. 6, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that it will report its interim result...
2024-08-06 07:30
3961
META Pharmaceuticals announces FDA Grants Rare Pediatric Disease Designation to META-001-PH for the Treatment of Primary Hyperoxaluria
HONG KONG, Aug. 5, 2024 /PRNewswire/ -- META Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation (RPDD) to its investigational new drug META-001-PH for the treatment of primary hyperoxaluria (PH).Primary hyperoxaluria is a...
2024-08-05 21:52
2712
Shanton Reaches Full Enrollment in Phase 2b Refractory/Tophaceous Gout Study with SAP-001
SAP-001 is Shanton's lead investigational compound with Best-in-Class potential in uncontrolled gout PRINCETON, N.J., Aug. 5, 2024 /PRNewswire/ -- Shanton Pharma, a clinical-stage biotech company developing a groundbreaking treatment for refractory and tophaceous gout patients, today announced f...
2024-08-05 21:00
2385
Seegene Showcased its Multiplex Technology at ADLM 2024
- Exhibited multiplex PCR testing technologies that provide comprehensive results from a single test - Presented high-multiplex assays and automated testing systems - Introduced the SG OneSystem™ business, the company's global technology-sharing initiative SEOUL, South Korea, Aug. 5, 2024 /P...
2024-08-05 21:00
3286
PENTAX Medical Receives FDA Clearance for Duodenoscope with New Sterilization Technology in Collaboration with Advanced Sterilization Products.
TOKYO, Aug. 5, 2024 /PRNewswire/ -- PENTAX Medical, a division of HOYA group, proudly announces FDA clearance of the DEC™ Duodenoscope (ED34-i10T2s) compatibility with the STERRAD™ 100NX Sterilizer, the flagship product from Advanced Sterilization Products (ASP), a division of Fortive. The colla...
2024-08-05 20:00
2887
Antennova Announces CD73 Small Molecule Inhibitor Accepted for Mini Oral Presentation at ESMO Congress 2024
BOSTON, Aug. 5, 2024 /PRNewswire/ -- Antennova, a clinical-stage biotech company focused on oncology today announced that the orally administered CD73 small molecule inhibitor ATN-037(also known as ATG-037) has been accepted for Mini Oral presentation at the 2024 European Society of Medical Oncol...
2024-08-05 20:00
2327
QBIOTICS WELCOMES STEPHEN DOYLE AS CHIEF EXECUTIVE OFFICER
* Stephen Doyle has more than 24 years of experience in the global pharmaceutical industry, including leadership positions with companies such as Sanofi Aventis and Boehringer Ingelheim. He was most recently Chief Business Officer at Aslan Pharmaceuticals. * Mr Doyle brings extensive knowledg...
2024-08-05 19:00
3176
So-Young to Report Second Quarter 2024 Financial Results on August 23, 2024
BEIJING, Aug. 5, 2024 /PRNewswire/ -- So-Young International Inc. (NASDAQ: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that it will report its financ...
2024-08-05 17:00
3260
Formosa Pharmaceuticals Announces Licensing Agreement with Apotex Inc., for Commercialization of Clobetasol Propionate Ophthalmic Suspension for Ocular Surgery Relief and Recovery
TAIPEI, Aug. 5, 2024 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals (" Formosa", 6838.TWO) announced today that the company has entered into an exclusive licensing agreement with Apotex Inc. ("Apotex"), for exclusive rights inCanada to the commercialization of clobetasol propionate ophthalmi...
2024-08-05 16:30
2354
Siriraj Hospital Integrates AI to Elevate Medical Research and Diagnosis, Touts YOLO Model for Centroblast Cell Counting
BANGKOK, Aug. 5, 2024 /PRNewswire/ -- The Faculty of Medicine Siriraj Hospital at Mahidol University has announced the integration of artificial intelligence (AI) technology to improve medical analysis and diagnostic capabilities. This initiative aims to enhance accuracy in detecting abnormalitie...
2024-08-05 11:53
2545
DKSH and Kyowa Kirin Forge Strategic Partnership Across Asia-Pacific
DKSH has signed a strategic business partnership with Kyowa Kirin, a Japan -based global specialty pharmaceutical company, to provide comprehensive services for their specialty drugs in South Korea, Taiwan region, Singapore, Thailand, Malaysia and Hong Kong & Macau SAR. With DKSH's expertise, dis...
2024-08-05 10:34
17866
INAUGURAL NUHS SCIENTIFIC & INNOVATION SUMMIT CHAMPIONS PREDICTIVE, PRECISE AND PERSONALISED CARE
From digital twin technology to leveraging AI in tackling obesity, the NUHS Scientific & Innovation Summit is a congregation of the brightest minds in cutting-edge medicine – with patients' utmost care at heart SINGAPORE, Aug. 3, 2024 /PRNewswire/ -- Hepatocellular carcinoma (HCC) is one of the ...
2024-08-03 14:02
4630
MTD Group completes the acquisition of Ypsomed's Pen Needles and Blood Glucose Monitoring Systems and announces a significant investment plan for its European production sites
MILAN, Aug. 2, 2024 /PRNewswire/ -- Medical Technology and Devices (MTD) is pleased to announce the successful closing of the acquisition of Ypsomed's Pen Needles and Blood Glucose Monitoring Systems (BGM) businesses, a strategic acquisition initially announced at the end of March. This acquisiti...
2024-08-02 13:00
4034
Innovent and SanegeneBio Announce First Participant Dosed in a Phase 1 Clinical Trial of IBI3016 (AGT siRNA)
SAN FRANSCISO and SUZHOU, China, Aug. 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic,...
2024-08-02 08:37
4290
RingConn Launches Gen 2 Smart Ring: Pioneering Sleep Apnea Detection with Unmatched 10 - 12 Days Battery Life
World's Leading Provider of Cutting-Edge Smart Ring Solutions
NEW YORK, Aug. 2, 2024 /PRNewswire/ -- RingConn
2024-08-02 00:00
5262
Week's Top Stories
Most Reposted
Marina Bay precinct partners UOB, Marina Bay Sands and Singapore Tourism Board, together with Disney Cruise Line, to illuminate Singapore's skyline with a fireworks sky show
[Picked up by 328 media titles]
2026-02-19 14:30
Never Miss a Message: Agoda's Customer Support Now Travels With You
[Picked up by 326 media titles]
2026-02-24 12:00
NextFin Asia: A New Dedicated Fund for the Catapult: Inclusion SE Asia Program to Further Scale Inclusive Finance Fintechs in ASEAN
[Picked up by 311 media titles]
2026-02-23 08:00
Klook and Osaka Convention & Tourism Bureau sign MoU to advance inbound tourism and foster socio-economic development throughout Osaka Prefecture
[Picked up by 301 media titles]
2026-02-24 16:13
Vitafoods Asia 2026 Expands by 30%: A Bigger, More Dynamic Trade Event with Exciting New Features & Increased International Participation
[Picked up by 288 media titles]
2026-02-23 10:09
Most Read
/C O R R E C T I O N -- Republic Power Group Limited (NASDAQ: RPGL)/
2026-02-20 06:36
8349